Israel has developed a new instrument for detecting liver disease in just 20 minutes
Release date: 2007-06-18 In a major breakthrough for medical diagnostics, Israel has introduced a groundbreaking device called "BreathID" that can detect liver disease in just 20 minutes. This innovative tool, developed by a high-tech Israeli company, offers a fast, non-invasive, and highly accurate alternative to traditional liver biopsies. By eliminating the need for painful and time-consuming procedures, BreathID significantly improves patient comfort and streamlines the diagnostic process. The technology behind BreathID is based on the "Molecular Correlation Energy Method," which involves continuous breath sampling. It measures the ratio of carbon-13 to carbon-12 in exhaled carbon dioxide at a level of one million parts per million. This unique approach allows doctors to assess liver function by analyzing how the body metabolizes a specific drug containing carbon-13 (mesalazine). After the patient ingests the drug, the device captures detailed metabolic data, which is then compared with standard biopsy results to determine if any abnormalities exist in liver function. With over 60 patented technologies, BreathID represents a significant advancement in medical science. Its development originated from an earlier research initiative focused on using breath analysis to diagnose stomach-related conditions. Today, this revolutionary technology has found a powerful application in liver disease detection, offering a safer, more efficient, and less intrusive method for patients and healthcare providers alike. Xuzhou Guifeng Metal Technology Co., Ltd , https://www.guifengmetal.com